Overexpression of the αvβ6 integrin in endometrial cancer

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 6, 2008, Pages 543-547

  Hecht, Jonathan L ^a   Dolinski, Brian M ^b   Gardner, Humphrey A ^b   Violette, Shelia M ^b   Weinreb, Paul H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BIOGEN   (United States)

Author keywords

v 6; Carcinoma; Endometrial; Endometrioid; Integrin

Indexed keywords

ALPHAVBETA6 INTEGRIN; MONOCLONAL ANTIBODY; BETA INTEGRIN; BETA6 INTEGRIN; CD51 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRECANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAV; INTEGRIN BETA CHAINS; LYMPHATIC METASTASIS; MIDDLE AGED;

EID: 67650311997     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31816bc5ee     Document Type: Article

References (23)

1. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
2. Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319-328. (Pubitemid 29077586)
3. Thomas GJ, Lewis MP, Whawell SA, et al. Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol. 2001;117:67-73. (Pubitemid 32652441)
4. Li X, Yang Y, Hu Y, et al. Alphavbeta6-Fyn signaling promotes oral cancer progression. J Biol Chem. 2003;278:41646-41653.
5. Agrez MV, Bates RC. Colorectal cancer and the integrin family of cell adhesion receptors: current status and future directions. Eur J Cancer. 1994;30A:2166-2170.
6. Janes SM, Watt FM. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol. 2004;166:419-431.
7. Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005;115:339-347.
8. Zambruno G, Marchisio PC, Marconi A, et al. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol. 1995;129:853-865.
9. Breuss JM, Gallo J, DeLisser HM, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108(Pt 6): 2241-2251.
10. Xue H, Atakilit A, Zhu W, et al. Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun. 2001;288:610-618.
11. Arihiro K, Kaneko M, Fujii S, et al. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer. 2000;7:19-26.
12. Ahmed N, Pansino F, Clyde R, et al. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis. 2002;23:237-244.
13. Kawashima A, Tsugawa S, Boku A, et al. Expression of alphav integrin family in gastric carcinomas: increased alphavbeta6 is associated with lymph node metastasis. Pathol Res Pract. 2003;199: 57-64. (Pubitemid 36519495)
14. Ahmed N, Niu J, Dorahy DJ, et al. Direct integrin alphavbeta6- ERK binding: implications for tumour growth. Oncogene. 2002;21: 1370-1380. (Pubitemid 34214502)
15. Weinreb PH, Simon KJ, Rayhorn P, et al. Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem. 2004;279:17875-17887. (Pubitemid 38560556)
16. Ruiter DJ, Ferrier CM, van Muijen GN, et al. Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 concerted action on clinical relevance of proteases in tumour invasion and metastasis. Eur J Cancer. 1998;34:1334-1340.
17. Ramos DM, But M, Regezi J, et al. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol. 2002;21:297-307. (Pubitemid 34497020)
18. Nystrom ML, Thomas GJ, Stone M, et al. Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol. 2005;205:468-475. (Pubitemid 40361335)
19. Nystrom ML, McCulloch D, Weinreb PH, et al. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Cancer Res. 2006;66:10833-10842.
20. Lessey BA, Ilesanmi AO, Lessey MA, et al. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am J Reprod Immunol. 1996;35:195-204.
21. Puy LA, Pang C, Librach CL. Immunohistochemical analysis of alphavbeta5 and alphavbeta6 integrins in the endometrium and endometriosis. Int J Gynecol Pathol. 2002;21:167-177.
22. Mutter GL, Baak JP, Crum CP, et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol. 2000;190:462-469.
23. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24:4783-4791.